(Q44299545)

English

Myeloperoxidase immunohistochemistry as a measure of disease activity in ulcerative colitis: association with ulcerative colitis-colorectal cancer, tumor necrosis factor polymorphism and RUNX3 methylation

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Myeloperoxidase immunohistochemistry as a measure of disease activity in ulcerative colitis: association with ulcerative colitis-colorectal cancer, tumor necrosis factor polymorphism and RUNX3 methylation (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

colorectal cancer

1 reference

based on heuristic

inferred from title

immunohistochemistry

1 reference

based on heuristic

inferred from title

ulcerative colitis

1 reference

based on heuristic

inferred from title

William Jeffery Sandborn

3

object named as

William J Sandborn

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Edward V Loftus

2

object named as

Edward V Loftus

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Thomas C. Smyrk

4

object named as

Thomas C Smyrk

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

author name string

Megan Garrity-Park

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

publication date

18 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Inflammatory Bowel Diseases

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

275-283

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Ulcerative colitis and colorectal cancer. A population-based study

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21681

21 January 2018

The risk of colorectal cancer in ulcerative colitis: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21681

21 January 2018

Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21681

21 January 2018

Epidemiology and risk factors for colorectal dysplasia and cancer in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21681

21 January 2018

Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21681

21 January 2018

Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21681

21 January 2018

MHC Class II alleles in ulcerative colitis-associated colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21681

21 January 2018

Epithelial cells bearing class II molecules stimulate allogeneic human colonic intraepithelial lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21681

21 January 2018

Potential role of Th17 cells in the pathogenesis of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21681

21 January 2018

Tumor necrosis factor-alpha polymorphisms in ulcerative colitis-associated colorectal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21681

21 January 2018

Epigenetic gene silencing by Runx proteins

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21681

21 January 2018

Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21681

21 January 2018

Epigenetic basis for aberrant upregulation of autoantigen genes in humans with ANCA vasculitis

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21681

21 January 2018

Epigenetic inactivation of RUNX3 in microsatellite unstable sporadic colon cancers

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21681

21 January 2018

Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21681

21 January 2018

RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21681

21 January 2018

The expression profile of functional regulatory T cells, CD4+CD25high+/forkhead box protein P3+, in patients with ulcerative colitis during active and quiescent disease.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21681

21 January 2018

Expression and functional characterization of FOXP3+ CD4+ regulatory T cells in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21681

21 January 2018

Distinct molecular patterns based on proximal and distal sporadic colorectal cancer: arguments for different mechanisms in the tumorigenesis.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21681

21 January 2018

Optimal indications of endocrine therapy alone as adjuvant systemic treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21681

21 January 2018

Inflammation: gearing the journey to cancer

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21681

21 January 2018

Oxidative DNA damage in the mucosa of ulcerative colitis increases with disease duration and dysplasia

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21681

21 January 2018

An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21681

21 January 2018

Genetic variants in SOD2, MPO, and NQO1, and risk of ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21681

21 January 2018

Nitric oxide and TNF-alpha trigger colonic inflammation and carcinogenesis in Helicobacter hepaticus-infected, Rag2-deficient mice

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21681

21 January 2018

Unravelling the pathogenesis of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21681

21 January 2018

Common immunologic mechanisms in inflammatory bowel disease and spondylarthropathies

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21681

21 January 2018

Recent developments in the immunology of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21681

21 January 2018

Selective decrease in colonic CD56(+) T and CD161(+) T cells in the inflamed mucosa of patients with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21681

21 January 2018

Regulatory T cells in patients with inflammatory bowel diseases treated with adacolumn granulocytapheresis

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21681

21 January 2018

Hyperactivated B cells in human inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21681

21 January 2018

Diagnosis and management of dysplasia in patients with ulcerative colitis and Crohn's disease of the colon

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21681

21 January 2018

Cancer in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21681

21 January 2018

Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21681

21 January 2018

Surveillance issues in inflammatory bowel disease: ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21681

21 January 2018

A reproducible grading scale for histological assessment of inflammation in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21681

21 January 2018

Infliximab reduces myeloperoxidase concentration in chronic inflammatory joint diseases.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21681

21 January 2018

Interpretation and quantification of immunostains

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21681

21 January 2018

Myeloperoxidase-positive cell infiltration in colorectal carcinogenesis as indicator of colorectal cancer risk

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21681

21 January 2018

Identifiers

10.1002/IBD.21681

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44299545&oldid=2109275103"